Article PDF
Avoid common mistakes on your manuscript.
References
Gepts E. Pharmacokinetic concepts for TCI anaesthesia. Anaesthesia 1998; 53: 4–12.
Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer controlled infusions. J Pharmacokinet Biopharm 1992; 20: 63–94.
Coetzee JF, Glen JB, Wium CA, Boshoff L. Pharmacokinetic model selection for target controlled infusions of propofol. Anesthesiology 1995; 82: 1328–45.
Vuyk J, Engbers FHM, Burm AGL, Wetter AA, Bovill JG. Performance of computer-controlled infusion of propofol: an evaluation of five pharmacokinetic parameter sets. Anesth Analg 1995; 81: 1275–82.
Glen JB. The development of “Diprifusor”: a TCI system for propofol. Anaesthesia 1998; 53: 13–21.
Marsh B, White M, Morton N, Kenny NC. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41–8.
Swinhoe CF, Peacock JE, Glen JB, Reilly CS. Evaluation of the predictive performance of a “Diprifusor” TCI system. Anaesthesia 1998; 53: 61–7.
Gepts E, Camu F, Cockshott ID, Douglas J. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66: 1256–63.
Sbafer A, Doze VA, Shafer SL, White PR Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988; 69: 348–56.
Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS. Pharmacokinetics of propofol (diprivan) in elderly patients. Br J Anaesth 1988; 60: 146–50.
Cockshott ID, Briggs LP, Douglas EJ, White M. Pharmacokinetics of propofol in female patients. Br J Anaesth 1987; 59: 1103–10.
Tackley RM, Lewis GTR, Prys-Roberts C, Boaden RW, Dixon J, Harvey JT. Computer controlled infusion of propofol. Br J Anaesth 1989; 62: 46–53.
Chortkoff BS, Eger EI, Crankshaw DP, Gonsowski CT, Dutton RC, Ionescu P. Concentrations of desflurane and propofol that suppress response to command in humans. Anesth Analg 1995; 81: 737–43.
Vuyk J, Engbers FHM, Lemmens HJM, et al. Pharmacodynamics of propofol in female patients. Anesthesiology 1992; 77: 3–9.
Forrest FC, Tooley MA, Saunders PR, Prys-Roberts C. Propofol infusion and the suppression of consciousness: the EEG and dose requirements. Br J Anaesth 1994; 72: 35–41.
Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994; 81: 820–8.
Vuyk J, Lim T, Erybers FHM, Burm AGL, Wetter AA, Bovill JG. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. Anesthesiology 1995; 83: 8–22.
Vuyk J, Mertens MJ, Olofsen E, Burm AGL, Bovill JG. Propofol anesthesia and rational opioid selection. Anesthesiology 1997; 87: 1549–62.
Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74: 53–63.
Egan TD, Minto CF, Hermann DJ, Barr JB, Muir KT, Shafer SL. Remifentanil versus alfentanil. Anesthesiology 1996; 84: 821–33.
Egan TD, Huizinga, B, Gupta S, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998; 89: 562–73.
Bouillon T, Shafer SL. Does size matter? Anesthesiology 1998; 89: 557–60.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fiset, P. Practical pharmacokinetics as applied to our daily anesthesia practice. Can J Anesth 46 (Suppl 5), R122–R130 (1999). https://doi.org/10.1007/BF03013188
Issue Date:
DOI: https://doi.org/10.1007/BF03013188